Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04416893

Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2) (WHO)

Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children, a Cross-sectional, Prospective, Multicentre, Observational Study in Primary Care-Part 2 After the Lifting of the Lockdown

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Centre Hospitalier Intercommunal Creteil · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Accepted

Summary

France and in particular the paris area was one of the countries most affected by the pandemic Covid19. School closures and a generalized lockdown of the population were instituted in France from 17 March 2020 to 10 May 2020. Schools and nurseries have reopened partially since 11 May 2020. From 2 June, this reopening is more widespread. By combining the search for SARS-Cov2 viruses by PCR and micro-method serology we will be able to evaluate both the infection at a given time and also older contact with SARS-CoV2. The temporal knowledge of the prevalence of SARS-Cov2 carriage and the serological status (IgM and IgG) after return to the community are crucial information to evaluate the speed of spread of the virus in children. This is the objective of COVILLE2, phase 2 of the COVILLE study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRT-PCR SARS-Cov2nasopharyngeal swab will be taken for detection of SARS-CoV-2 by RT-PCR
DIAGNOSTIC_TESTSars-Cov2 serologyA microsample of blood will be taken for serology

Timeline

Start date
2020-11-01
Primary completion
2021-01-01
Completion
2021-04-01
First posted
2020-06-04
Last updated
2021-05-27

Source: ClinicalTrials.gov record NCT04416893. Inclusion in this directory is not an endorsement.